However, Ehinger et al [53] observed that patients with luminal breast cancer (ER+/HER2-) of histological grade G3 have a similar prognosis factor, regardless of whether they are classified as luminal A or B based on the Ki-67 proliferative index and qualitative PR expression. This evidence concerns the gene MKI67 and breast cancer.